Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

  1. Lara-Morga, C.
  2. Palka-Kotlowska, M.
  3. Custodio-Cabello, S.
  4. Pacheco-Barcia, V.
  5. Cabezón-Gutiérrez, L.
Aldizkaria:
Exploration of Targeted Anti-tumor Therapy

ISSN: 2692-3114

Argitalpen urtea: 2023

Alea: 4

Zenbakia: 2

Orrialdeak: 307-315

Mota: Artikulua

DOI: 10.37349/ETAT.2023.00136 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak